X

This is not a paywall.

Register for free to continue reading.

The news sucks. But your reading experience doesn't have to. Help us improve that for you by registering for free.



Please create a password or click to receive a login link.


Please enter your password or get a login link if you’ve forgotten


Open Sesame! Thanks for registering.

First Thing, Daily Maverick's flagship newsletter

Join the 230 000 South Africans who read First Thing newsletter.

A South African Hero: You

There’s a 99.7% chance that this isn’t for you. Only 0.3% of our readers have responded to this call for action.

Those 0.3% of our readers are our hidden heroes, who are fuelling our work and impacting the lives of every South African in doing so. They’re the people who contribute to keep Daily Maverick free for all, including you.

We need so many more of our readers to join them. The equation is quite simple: the more members we have, the more reporting and investigations we can do, and the greater the impact on the country. We are inundated with tip-offs; we know where to look and what to do with the information when we have it – we just need the means to help us keep doing this work.

Be part of that 0.3%. Be a Maverick. Be a Maverick Insider.

Support Daily Maverick→
Payment options

Pfizer Covid vaccines safe and effective for small chil...

Business Maverick

Business Maverick

Pfizer Covid vaccines safe and effective for small children, FDA staff say

A child receives a dose of the Pfizer-BioNTech COVID-19 vaccine in West Bloomfield, Michigan, US, on Thursday, November 4, 2021. Younger children, ages 5 to 11-year-old, across the U.S. are now eligible to receive Pfizer's Covid-19 vaccine, after the head of the Centers for Disease Control and Prevention granted the final clearance needed for shots to begin.
By Reuters
13 Jun 2022 0

Covid-19 shots for children under the age of six are yet not approved in most parts of the world. And while demand for the vaccines for younger children has been low, it is expected to pick up once the vaccines gain authorisation.

US Food and Drug Administration staff reviewers on Sunday said Pfizer-BioNTech’s Covid-19 vaccines were effective and safe for use in children aged six months to four years. 

The FDA reviewers said in briefing documents published on Sunday evening that their evaluation did not reveal any new safety concerns related to the use of the vaccine in young children.

The FDA analysis of data from Pfizer’s trial was published ahead of a June 15 meeting of its outside advisers. Recommendations from the external advisers will determine the FDA’s decision on the vaccines.

“Available data support the effectiveness of the Pfizer-BioNTech Covid-19 vaccine 3-dose primary series in preventing Covid-19 in the age group of 6 months through 4 years,” FDA staff said in the review.

An early analysis of data from Pfizer-BioNTech’s vaccine based on 10 symptomatic Covid-19 cases identified when the Omicron coronavirus variant was dominant suggested a vaccine efficacy of 80.3% in the under-5 age group.Covid-19 shots for children under the age of six are yet not approved in most parts of the world. 

It remains unclear how many parents will get their young ones vaccinated as demand has been low for kids aged five to 11.

US President Joe Biden’s administration expects vaccinations for young children to begin in earnest as early as June 21 if the FDA and the Centers for Disease Control and Prevention approve the vaccines. Read full story

Government officials say pre-orders for use in the under-6 age group has been low but demand is expected to pick up once the vaccines gain authorisation.

The FDA on Friday released a staff review of Moderna Inc’s MRNA.O Covid-19 vaccine which said the doses were safe and effective for use in children aged six months to 17 years old. BM


Gallery

Comments - share your knowledge and experience

Please note you must be a Maverick Insider to comment. Sign up here or sign in if you are already an Insider.

Everybody has an opinion but not everyone has the knowledge and the experience to contribute meaningfully to a discussion. That’s what we want from our members. Help us learn with your expertise and insights on articles that we publish. We encourage different, respectful viewpoints to further our understanding of the world. View our comments policy here.

No Comments, yet

Please peer review 3 community comments before your comment can be posted